recent post

Bio-Absorbable Screws: Transforming Orthopaedic Care with Cutting-Edge Innovation

December 10, 2024
recent post

Union Health Minister Nadda launches 100-day intensified nationwide campaign to reduce TB incidence

recent post

Metropolis Healthcare acquires 100% stake in Core Diagnostics for Rs 246 cr

December 9, 2024
recent post

BPCL with Smile Train supports underserved communities in Sagar district, MP

recent post

Aster CMI Hospital, Govt of Arunachal Pradesh MoU to provide liver transplantation services

JNCASR research finds new route to Monkeypox detection

JNCASR research finds new route to Monkeypox detection

Additional mapping of the MPV genome is being performed to identify potential GQ targets for future therapeutics

Scientists from JNCASR, an autonomous institution of the Department of Science and Technology (DST), have identified and characterised highly conserved GQ forming DNA sequences—a set of four, within the MPV genome, and specifically detected a specific GQ sequence using a tailored fluorescent small-molecule probe, enabling precise detection of MPV. The identification, characterisation and targeting of unusual nucleic acid structures such as GQs have therapeutic implications.

These GQ sequences are stable under physiological conditions, highly conserved and are not present in other pox viruses, other pathogens, and the human genome. These characteristics make the GQ sequences valuable targets for the development of diagnostic tools and therapeutic intervention.

The fluorogenic molecular probe (BBJL) developed by Sumon Pratihar, Ramjayakumar Venkatesh, Mohamed Nabeel Mattath, and Thimmaiah Govindaraju also delivers more than 250-fold enhancement in fluorescence output upon binding with an MPV GQs (MP2). The ability of BBJL to selectively detect this highly conserved sequence in the MPV genome sets a precedent for the development of detection techniques targeting noncanonical nucleic acids.

The molecular probe is non-fluorescent in the absence of the target GQ-DNA and is the first practical demonstration of a GQ-targeted diagnostic strategy for the detection of Monkeypox virus (MPV). This represents the expansion of their modular diagnostic platform, GQ-targeted reliable conformation polymorphism (GQ-RCP), which was originally developed for the detection of SARS-CoV-2/COVID-19, by identifying MPV/Mpox-specific GQs and a novel fluorogenic probe which was earlier published in ACS Sensors.

The sensitive probe can efficiently distinguish the target MPV-derived GQ from diverse other GQs, and other DNA conformations derived from the human genome. The GQs identified in the MPV genome can also serve as potential anti-viral targets.

Additional mapping of the MPV genome is being performed to identify potential GQ targets for future therapeutics. Consequently, this study augments the development of potential detection platforms based on GQ, and the GQs identified can be further investigated for their anti-viral properties.

Such molecular probes with superior conformation or sequences specific recognition of nucleic acids could alleviate the challenge in existing amplification-based techniques, in discriminating false-positive results arising from non-specific amplification. The identification and characterization of new GQ sequences in monkeypox virus (MPV) could help the broader scientific community seeking to understand the virology of MPV or develop diagnostic and therapeutic interventions.

PIB